A reduction in the expression of a desmosomal protein DSC2 has been associated with shortened survival, high-grade malignancy and lymph node positivity in pancreatic tumor [123], and a decrease in DSC2 in colorectal cancer has also been observed [125]. Here, DSC2 is linked to colorectal cancer.